Japan Enhertu Nod Another Boost For Daiichi's Oncology Hopes
Second OK Globally After US
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
